Bristows

7/31/2025 8:51:24 AM

The double-edged sword of AI in femtech in the EU

By Ellie Handy Subhalakshmi Kumar Kiran Sidhu

AI presents many opportunities in the women’s health space, but it can also pose considerable risks. Anyone seeking to commercialise...

7/30/2025 3:01:07 PM

It’s time to act on the new R&D regime

By Julia Cockroft Tabitha Reed

Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...

7/30/2025 2:34:53 PM

Biotech Review of the Year: latest developments

By Bristows LLP

At the start of the year, our editors (Xisca Borrás, Katie Cambrook and Aida Tohala) presented to you the 12th edition of our Biotech...

7/30/2025 10:54:35 AM

Sarepta’s Duchenne difficulties: potential implications for gene therapy licensing

By Ellen Lambrix Luca Cericola

Earlier this year, we reported on key considerations that parties involved in the negotiation and drafting of financial milestone...

7/25/2025 8:54:32 AM

Licensing Executives Society Britain & Ireland 2025 Annual Conference: Licensing as a solution in an age of uncertainty

By Ellen Lambrix Luca Cericola

Earlier this month, Ellen Lambrix and Luca Cericola from Bristows’ Commercial & IP Transactions team attended the Licensing Executives...

7/24/2025 8:31:51 AM

Navigating early-stage funding for FemTech companies in the UK: Key insights for founders and investors

By Anna Honey Gabriela Necula

The FemTech sector — technology focused on women’s health and wellness — is experiencing rapid growth in the UK. Out of the 540 active...

7/17/2025 8:43:19 AM

Data, dignity and discretion: Navigating key GDPR challenges in women’s health

By Subhalakshmi Kumar Kiran Sidhu

One of the key challenges with closing the women’s health gap and expanding the number of offerings available to women (in an industry...

7/10/2025 8:23:18 AM

To Be Or Not To Be … A Medical Device – Is your Femtech software regulated as a medical device in the UK?

By Xisca Borrás Ellie Handy

Femtech, short for female technology, is an important and fast growing sector. The UK is a key market for femtech as it is ranked second...

5/15/2025 10:35:28 AM

Cell and Gene Therapy licensing: Complex regulatory pathways necessitate careful scrutiny of financial milestones

By Luca Cericola Ellen Lambrix Alex Denoon

This article was first published in the Bio-science Law Review (Volume 19, Issue 6) by Lawtext Publishing. Cell and Gene Therapies...

3/21/2025 9:45:58 AM

UK Pharma leaders: VPAG is making the UK “un-investable”

By Hugo Kent-Egan Alex Denoon Krishiv Desai

Various UK pharmaceutical companies yesterday co-signed a report warning that future UK investment is unlikely unless the Government...

3/17/2025 3:46:52 PM

Statutory Scheme repayments: the DHSC dots the i's and crosses the t's

By Hugo Kent-Egan

On Friday, the DHSC published the latest consultation to update the repayment percentage under the Statutory Scheme. This consultation...

3/12/2025 3:06:22 PM

Over a year on from VPAG: is there a VAT-shaped hole in the Government’s calculations?

By Tabitha Reed Hugo Kent-Egan Julia Cockroft +1 more...

HMRC has been granted permission to appeal the First-Tier Tribunal’s VAT decision in the case of Boehringer Ingelheim Ltd v HMRC. We...